Stock Events

CRISPR Therapeutics (CRSP) Q3 2024 Earnings

CRSP -1.77%
5AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.96
-0.94
0.08
1.1

Details

Expected EPS
-1.427466
Actual EPS
-1.49
Surprise EPS
-0.06
Surprise Percent
+4.38%

Description

CRISPR Therapeutics (CRSP) has reported earnings of -1.49 per share for Q3 2024.

0 Comments

Share your thoughts